Biotika a.s. (BSSE: 1BSL01AE)
Health Care · Pharmaceuticals · SK
€17.00
-15.00% today · +142.9% 1Y
Biotika a.s. (BSSE: 1BSL01AE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.73M.
Over the last twelve months the share price has gained 142.9%, trading between 7.00 and 23.00.
Tweenvest scores Biotika a.s. across four factors: quality 53/100, value 67/100, growth 60/100. Its strongest factor is value.
1BSL01AE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.73M
- Revenue (TTM)
- $21.31M
- P/E
- —
- EPS
- -1.70
- Dividend yield
- —
- Beta (5Y)
- 0.05
- 52-week high
- €23.00
- 52-week low
- €7.00
- Avg volume (3M)
- —
- Shares outstanding
- 700.00K
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.